loadpatents
Patent applications and USPTO patent grants for ERHO; Nicholas George.The latest application filed is for "use of immune cell-specific gene expression for prognosis of prostate cancer and prediction of responsiveness to radiation therapy".
Patent | Date |
---|---|
Use Of Immune Cell-specific Gene Expression For Prognosis Of Prostate Cancer And Prediction Of Responsiveness To Radiation Therapy App 20210317531 - DAVICIONI; Elai ;   et al. | 2021-10-14 |
Cancer diagnostics using biomarkers Grant 11,035,005 - Buerki , et al. June 15, 2 | 2021-06-15 |
Cancer diagnostics using non-coding transcripts Grant 10,513,737 - Davicioni , et al. Dec | 2019-12-24 |
Cancer Biomarkers And Classifiers And Uses Thereof App 20160032395 - Davicioni; Elai ;   et al. | 2016-02-04 |
Cancer Diagnostics Using Non-Coding Transcripts App 20150011401 - Davicioni; Elai ;   et al. | 2015-01-08 |
Cancer Diagnostics Using Biomarkers App 20140066323 - Buerki; Christine ;   et al. | 2014-03-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.